Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Pre-clinical and clinical development of the first placental malaria vaccine

Research output: Contribution to journalReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{96d141a2cc7b405ba1c542dd40a20fb5,
title = "Pre-clinical and clinical development of the first placental malaria vaccine",
abstract = "INTRODUCTION: Malaria during pregnancy is a massive health problem in endemic areas. Placental malaria infections caused by Plasmodium falciparum are responsible for up to one million babies being born with a low birth weight every year. Significant efforts have been invested into preventing the condition. Areas covered: Pub Med was searched using the broad terms 'malaria parasite placenta' to identify studies of interactions between parasite and host, 'prevention of placental malaria' to identify current strategies to prevent placental malaria, and 'placental malaria vaccine' to identify pre-clinical vaccine development. However, all papers from these searches were not systematically included. Expert commentary: The first phase I clinical trials of vaccines are well underway. Trials testing efficacy are more complicated to carry out as only women that are exposed to parasites during pregnancy will contribute to endpoint measurements, further it may require extensive follow-up to establish protection. Future second generation vaccines may overcome the inherent challenges in making an effective placental malaria vaccine.",
keywords = "Clinical Trials, Phase I as Topic, Drug Discovery, Drug Evaluation, Preclinical, Female, Humans, Malaria Vaccines, Malaria, Falciparum, Placenta Diseases, Plasmodium falciparum, Pregnancy, Pregnancy Complications, Infectious, Journal Article, Review, Research Support, Non-U.S. Gov't",
author = "Caroline Pehrson and Ali Salanti and Theander, {Thor G} and Nielsen, {Morten A}",
year = "2017",
month = jun,
doi = "10.1080/14760584.2017.1322512",
language = "English",
volume = "16",
pages = "613--624",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd",
number = "6",

}

RIS

TY - JOUR

T1 - Pre-clinical and clinical development of the first placental malaria vaccine

AU - Pehrson, Caroline

AU - Salanti, Ali

AU - Theander, Thor G

AU - Nielsen, Morten A

PY - 2017/6

Y1 - 2017/6

N2 - INTRODUCTION: Malaria during pregnancy is a massive health problem in endemic areas. Placental malaria infections caused by Plasmodium falciparum are responsible for up to one million babies being born with a low birth weight every year. Significant efforts have been invested into preventing the condition. Areas covered: Pub Med was searched using the broad terms 'malaria parasite placenta' to identify studies of interactions between parasite and host, 'prevention of placental malaria' to identify current strategies to prevent placental malaria, and 'placental malaria vaccine' to identify pre-clinical vaccine development. However, all papers from these searches were not systematically included. Expert commentary: The first phase I clinical trials of vaccines are well underway. Trials testing efficacy are more complicated to carry out as only women that are exposed to parasites during pregnancy will contribute to endpoint measurements, further it may require extensive follow-up to establish protection. Future second generation vaccines may overcome the inherent challenges in making an effective placental malaria vaccine.

AB - INTRODUCTION: Malaria during pregnancy is a massive health problem in endemic areas. Placental malaria infections caused by Plasmodium falciparum are responsible for up to one million babies being born with a low birth weight every year. Significant efforts have been invested into preventing the condition. Areas covered: Pub Med was searched using the broad terms 'malaria parasite placenta' to identify studies of interactions between parasite and host, 'prevention of placental malaria' to identify current strategies to prevent placental malaria, and 'placental malaria vaccine' to identify pre-clinical vaccine development. However, all papers from these searches were not systematically included. Expert commentary: The first phase I clinical trials of vaccines are well underway. Trials testing efficacy are more complicated to carry out as only women that are exposed to parasites during pregnancy will contribute to endpoint measurements, further it may require extensive follow-up to establish protection. Future second generation vaccines may overcome the inherent challenges in making an effective placental malaria vaccine.

KW - Clinical Trials, Phase I as Topic

KW - Drug Discovery

KW - Drug Evaluation, Preclinical

KW - Female

KW - Humans

KW - Malaria Vaccines

KW - Malaria, Falciparum

KW - Placenta Diseases

KW - Plasmodium falciparum

KW - Pregnancy

KW - Pregnancy Complications, Infectious

KW - Journal Article

KW - Review

KW - Research Support, Non-U.S. Gov't

U2 - 10.1080/14760584.2017.1322512

DO - 10.1080/14760584.2017.1322512

M3 - Review

C2 - 28434376

VL - 16

SP - 613

EP - 624

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 6

ER -

ID: 52820935